GREY:COTQF - Post by User
Comment by
Cotitwoon Feb 02, 2019 2:30pm
230 Views
Post# 29310363
RE:Stock on nice roll - up .07 to .18C
RE:Stock on nice roll - up .07 to .18CJust to clarify if need be all 3 patients have been dosed in Cohort 1
The first patient was dosed on Jan 14 which would mean he/she would of completed 3 weeks
The other 2 started this past Monday so there done Feb 15
Once the 3 people have completed there 3 week cycle Cohort 2 can begin there cycle at a higher dose.
The company sent out an email yesterday inviting Existing and Potential Investors to a attend a meeting Feb 12 at Burlington Golf and Country Club at 1PM
The company will be providing an update on the Coti2 combination trial in solid tumors underway at MDACC , the planned Coti2 combination trial in Triple Negativw Breast Cancer at St. Vincents Hospital in Ireland as well as an update on corporate financing effort
There is no doubt they need money but this is also very exciting times.With any good results from the trials could be a major game changer for us
Alison told me she has met with the Japenese company Eisai who is providing the drug Eribulin
which will be used in combination with Coti2 to treat patients with Triple Negative Breast Cancer
She has been meeting with the principals of this company to form an alliance with them
Dr John Crown the oncologist from St Vincents is also ' Incredibly Excited'